Mind-Body Intervention for Long COVID

Mind Body Intervention for Long COVID-19

Recruiting N/A Interventional Study
Long COVID Post-Acute Sequelae of COVID-19 COVID Long-Haul
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
180 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Other
Who this trial is looking for

This trial is looking for adults with symptoms from Long COVID to see if a mind-body program can help. Participants will compare this program with regular care and another similar treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years or older
  • I have tested positive for COVID-19
  • I have symptoms only related to COVID-19
  • I score 10 or more on the SSS-8 questionnaire
  • I have symptoms at least 3 days a week for more than 3 months
  • I am willing to participate in a mind-body intervention

You may not be able to join if

  • I have a clear diagnosis of another physical disease
  • I was hospitalized in an intensive care unit for COVID-19
  • I am older than 65 years
  • I have a diagnosis of dementia or similar cognitive impairment
  • I have an active addiction disorder
  • I have a major psychiatric condition

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Adult (≥ 18 years of age) 2. Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing) 3. Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc) 4. A somatic symptom score ≥ 10 on the SSS-8 questionnaire…
Contacts

Ashley Scafetta

617-754-2882

ascafett@bidmc.harvard.edu

CONTACT